HYPERHEP B
GRIFOLS THERAPEUTICS LLC
Quick answers
Is there a shortage of HYPERHEP B in Canada?
No. There is no current shortage of HYPERHEP B 110UNIT reported to Health Canada. Stock can still vary from one pharmacy to another.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Other Products
HEPATITIS B IG INJ
CUTTER MED & BIOL, DIVISION OF MILES CANADA LTD.
H-BIG
ABBOTT LABORATORIES, LIMITED
HYPERHEP INJ
CUTTER MED & BIOL, DIVISION OF MILES CANADA LTD.
HYPERHEP B S/D
GRIFOLS THERAPEUTICS LLC
HEPAGAM B
KI BIOPHARMA LLC
HYPERHEP B
GRIFOLS THERAPEUTICS LLC
DIN
02520125
Strength
110UNIT
Dosage Form
Solution
Route
Intramuscular
Active Ingredient
HEPATITIS B IMMUNOGLOBULIN (HUMAN)
See all HEPATITIS B IMMUNOGLOBULIN (HUMAN) products →Compare with another product →
Product Monograph
Product monograph is not available from Health Canada
Shortage History
No shortage or discontinuation reports on file for this product.
Other Products from GRIFOLS THERAPEUTICS LLC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
25% · DIN 02223708
5% · DIN 02223694
18% · DIN 02486598
10G · DIN 02247724
220UNIT · DIN 02520001
300UNIT · DIN 02486571
250UNIT · DIN 02520087
10G · DIN 02277921
50MG · DIN 02189100
1000MG · DIN 02204606